WJPR Citation New

  All Since 2019
 Citation  7475  4312
 h-index  28  21
 i10-index  197  83

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

EVALUATION OF QUALITY OF LIFE (QOL) OF GERIATRIC PATIENTS DIAGNOSED WITH CONGESTIVE CARDIAC FAILURE (CCF) TREATED WITH METOPROLOL

M. Sudharsan, T. Naveen Pandian, D. Praveen Kumar, G. Sahaya Nirmal and Dr. B. Benjamin Prince*

.

Abstract

Aim: The main objective of this study is to evaluate the quality of life of geriatric patients diagnosed with congestive heart failure treated with metoprolol. Methods: A prospective observational study was conducted as per the protocol approved by the institutional ethics committee. Overall 56 cases were included in this study. Out of this 15 patients were diagnosed with mild heart failure, 19 patients were diagnosed with moderate heart failure and 22 patients were diagnosed with severe heart failure. All the demographic data, ECHO report, metoprolol treatment regimen, from the case reports were collected and documented in a pre-designed patient data entry form. Results: Based on the study criteria, 56 patients were selected and enrolled in this study. In this study, 26 (46.42%) subjects were male and 30 (53.57 %) subjects were female. The severity of the disease condition depends upon the age factor. Such that when age increases the severity of heart failure also increases. Out of this 40 patients were 60-70 years [Good QOL -29 patients (72.5%), Moderate QOL -10 patients(25%), Poor QOL- 1Patient (2.5%)], 9 patients were 71-80 years[Good QOL -6 patients (66.66 %), Moderate QOL -2 patients (22.22 %), Poor QOL – 1 Patient(11.11%)], 5 patients were 81-90 years [Good QOL – 3 Patients (60%)Moderate QOL – 1 patient (20 %), Poor QOL – 1 patient (20 %)] and 2 patient were 91-100 years[Poor QOL -2 (100 %)]. Conclusion: In our Study, Geriatric heart failure patients treated with Metoprolol reduced the risk of morbidity and evaluated the QOL of geriatric heart failure patients undergoing metoprolol treatment by using MLHFQ. Metoprolol increases the survival rate by improving the systolic and diastolic function thus improves the QOL by shifting the patient stage severity.

Keywords: Age, Quality of Life, Metoprolol, Heart failure.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More